RCM Technologies vs TrueBlue
RCMT and TBI side by side, both in personnel supply services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RCMT and TBI compare
TrueBlue is the larger company, worth 1.5 times as much as RCM Technologies ($381M against $248M).
TrueBlue grew revenue faster over the last twelve months (12.4% versus 8.7% for RCM Technologies).
RCM Technologies keeps more of each dollar of sales as profit, with a net margin of 5.2% compared with −2.6% at TrueBlue.
RCM Technologies scores higher on the StockData Score (12 against 6 for TrueBlue), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RCMT | TBI |
|---|---|---|
| Size and price | ||
| Market cap | $248M | $381M |
| Share price | $34.82 | $12.50 |
| Change, 1 year | 74.5% | 157% |
| Change, 5 years | 400% | −52.5% |
| Beta (5Y) | 0.57 | 1.18 |
| Employees | 250 | 3,500 |
| StockData Score | ||
| Total score | 12 (better) | 6 |
| Valuation score | 1 | 2 (better) |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 6 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 14.6× | – |
| P/S | 0.7× | 0.2× (better) |
| P/B | 4.7× | 1.4× (better) |
| EV/EBITDA | 8.6× | – |
| P/FCF | 12.0× | – |
| PEG | 6.41 | – |
| FCF yield | 8.3% (better) | −19.0% |
| Fair value | $33.87 | $14.81 |
| Margin of safety | −2.8% | 15.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.7% | 12.4% (better) |
| Revenue growth, 5Y average | 16.3% (better) | −2.6% |
| Net income growth (TTM) | 34.1% | – |
| EPS growth (TTM) | 39.2% | – |
| Profitability | ||
| Gross margin | 26.8% (better) | 20.6% |
| Operating margin | 7.8% (better) | −2.0% |
| Net margin | 5.2% (better) | −2.6% |
| FCF margin | 6.1% (better) | −4.1% |
| Return on equity | 37.2% (better) | −15.9% |
| Return on invested capital | 42.6% (better) | −8.6% |
| Financial health | ||
| Debt / equity | 0.00 | 0.38 (better) |
| Current ratio | 2.07 | 2.33 (better) |
| Altman Z-score | 5.73 (better) | 4.02 |
| Piotroski F-score | 8 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | 3.6% | – |
| Shareholder yield | 3.6% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 41.1% | 85.1% |
| Held by insiders | 33.3% | 7.8% |
| Insider net buying, 12 months | −$12.6M | $134K (better) |
| Short interest, % of float | 5.0% | 1.6% |
Go deeper
- RCMT stock overview
- RCMT income statement
- RCMT valuation and score
- TBI stock overview
- TBI income statement
- TBI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.